Thrombospondin-4 and its variants: Expression and differential effects on endothelial cells

Circulation

Volumn 108, Issue 12, 2003, Pages 1514-1519

  Stenina, Olga I ^a   Desai, Shailesh Y ^a   Krukovets, Irene ^a   Kight, Kelly ^a   Janigro, Damir ^a   Topol, Eric J ^a   Plow, Edward F ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NB50 ^*  (United States)

Author keywords

Atherosclerosis; Cells, adhesion; Cells, proliferation; Endothelium; Extracellular matrix

Indexed keywords

ALANINE; FOCAL ADHESION KINASE; PROLINE; THROMBOSPONDIN; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN BLOOD VESSEL; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; THROMBOSPONDIN 4 GENE; VASCULAR SMOOTH MUSCLE;

ARTERIOSCLEROSIS; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION; HUMANS; KIDNEY; MIDDLE CEREBRAL ARTERY; MUSCLE, SMOOTH, VASCULAR; MUTATION; PEPTIDE FRAGMENTS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-TYROSINE KINASES; RISK FACTORS; RNA, MESSENGER; THROMBOSPONDINS; TRANSFECTION;

EID: 0141615831     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000089085.76320.4E     Document Type: Article

References (21)

1. Topol EJ, McCarthy J, Gabriel S, et al. Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction. Circulation. 2001;104:2641-2644.
2. Yamada Y, Izawa H, Ichihara S, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347: 1916-1923.
3. Lawler J, Duquette M, Whittaker CA, et al. Identification and characterization of thrombospondin-4, a new member of the thrombospondin gene family. J Cell Biol. 1993;120:1059-1067.
4. Narouz-Ott L, Maurer P, Nitsche DP, et al. Thrombospondin-4 binds specifically to both collagenous and non-collagenous extracellular matrix proteins via its C-terminal domains. J Biol Chem. 2000;275:37110-37117.
5. Manoharan HT, Gallo J, Gulick AM, et al. High-level production and purification of biologically active proteins from bacterial and mammalian cells using the tandem pGFLEX expression system. Gene. 1997;193:229-237.
6. Desai SY, Marroni M, Cucullo L, et al. Mechanisms of endothelial survival under shear stress. Endothelium. 2002;9:89-102.
7. Lawler J, McHenry K, Duquette M, et al. Characterization of human thrombospondin-4. J Biol Chem. 1995;270:2809-2814.
8. Silverstein RL, Leung LL, Harpel PC, et al. Complex formation of platelet thrombospondin with plasminogen modulation of activation by tissue activator. J Clin Invest. 1984;74:1625-1633.
9. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem. 1991;266: 14831-14834.
10. Mumby SM, Raugi GJ, Bornstein P. Interactions of thrombospondin with extracellulax matrix proteins: selective binding to type V collagen. J Cell Biol. 1984;98:646-652.
11. Karczewski J, Knudsen KA, Smith L, et al. The interaction of thrombospondin with platelet glycoprotein GPII6-IIIa. J Biol Chem. 1989;264: 21322-21326.
12. Leung LLK, Li WX, McGregor JL, et al. CD36 peptides enhance or inhibit CD36 thrombospondin binding: a 2-step process of ligand-receptor interaction. J Biol Chem. 1992;267:18244-18250.
13. Dardik R, Lahav J. Functional changes in the conformation of thrombospondin-1 during complexation with fibronectin or heparin. Exp Cell Res. 1999;248:407-414.
14. Milev Y, Essex DW. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of thrombospondin-1 with thrombin-antithrombin III. Arch Biochem Biophys. 1999;361:120-126.
15. Murphy-Ullrich JE. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest. 2001;107: 785-790.
16. Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci. 1999;112(pt 16): 2677-2691.
17. Pawlak G, Helfman DM. Cytoskeletal changes in cell transformation and tumorigenesis. Curr Opin Genet Dev. 2001;11:41-47.
18. Krutzsch HC, Choe BJ, Sipes JM et al. Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1. J Biol Chem. 1999;274: 24080-24086.
19. Roth JJ, Gahtan V, Brown JL, et al. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J Surg Res. 1998;74:11-16.
20. Patel MK, Lymn JS, Clunn GF, et al. Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1997;17:2107-2114.
21. Slouffer GA, Hu Z, Sajid M, et al. Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation. 1998;97:907-915.